Agency Information Collection Activities: Proposed Collection; Comment Request, 10974-10975 [06-1919]
Download as PDF
10974
Federal Register / Vol. 71, No. 42 / Friday, March 3, 2006 / Notices
diseases; attitudes toward marriage,
childbearing, and parenthood; and
men’s and women’s roles in raising
children.
While the content of Cycle 7 will be
similar to that of Cycle 6, the
interviewing will be conducted over a
4.5-year period rather than all in one
year, as in previous cycles. This
continuous interviewing design is
intended to reduce costs, increase
efficiency, and contribute to continuous
improvement in the collection,
processing, and dissemination of the
data. Sample size is expected to increase
from 12,571 in Cycle 6 to 17,400 total
in the 4.5 years of data collection in
Cycle 7. For this cycle, the ‘‘Pretest’’
will be conducted initially in the first 8
weeks of interviewing and, if no
problems are found, those weeks will
become part of the Main Study. If
operational problems are found in that
period, they will be corrected, and the
‘‘Main Study’’ will begin at that point.
Emerging public policy issues may
necessitate the addition of a few new
questions. The burden table represents
the survey collection averaged over the
first three years of the survey.
Users of the NSFG include the
National Institutes of Health National
Institute of Child Health and Human
Development; the Office of Population
Affairs; NCHS/CDC; the Division of
Reproductive Health, CDC; the
Divisions of HIV/AIDS Prevention, CDC;
the Office of the Assistant Secretary for
Planning and Evaluation; and the
Administration for Children and
Families.
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
6,457
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Respondents/instruments
Pretest Screener ..........................................................................................................................
Males ...........................................................................................................................................
Females .......................................................................................................................................
Main study screener ....................................................................................................................
Males ...........................................................................................................................................
Females .......................................................................................................................................
Verification ...................................................................................................................................
Test new questions ......................................................................................................................
Dated: February 24, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–3024 Filed 3–2–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
wwhite on PROD1PC61 with NOTICES
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
The Health Department Subcommittee
of the Board of Scientific Counselors
(BSC), Centers for Disease Control and
Prevention (CDC), National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry:
Teleconference Meeting.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), The National Center
for Environmental Health/Agency for
Toxic Substances and Disease Registry
(NCEH/ATSDR), CDC announces the
following subcommittee teleconference
meeting:
Name: Health Department Subcommittee
(HDS), BSC, NCEH/ATSDR.
Time and Date: 1 p.m.–2:30 p.m., March
15, 2006.
VerDate Aug<31>2005
16:43 Mar 02, 2006
Jkt 208001
Number of
responses per
respondent
403
109
133
7,250
1,957
2,393
725
2,000
Average
burden per
response
(in hours)
1
1
1
1
1
1
1
1
5/60
1.00
1.33
5/60
1.00
1.33
5/60
10/60
Place: Century Center, 1825 Century
Boulevard, Atlanta, Georgia 30345.
Status: Open to the public, teleconference
access limited only by availability of
telephone ports.
Purpose: Under the charge of the BSC,
NCEH/ATSDR the Health Department
Subcommittee will provide the BSC, NCEH/
ATSDR with advice and recommendations
on local and state health department issues
and concerns that pertain to the mandates
and mission of NCEH/ATSDR.
Matters to be Discussed: The meeting
agenda will include a discussion of NCEH/
ATSDR’s inventory list of environmental
health training activities; a discussion of the
Office of Workforce and Career Development;
a discussion on the list of Environmental
Health training activities being conducted by
groups other than CDC; and a discussion on
formulating possible recommendations to the
BSC.
Items are subject to change as priorities
dictate.
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
NCEH/ATSDR.
Supplementary Information: To
participate in the meeting, public
comment period will be from 2–2:10
p.m. Eastern Standard Time. Dial (877)
315–6535 and enter conference code
383520.
For Further Information Contact:
Shirley D. Little, Committee
Management Specialist, NCEH/ATSDR,
1600 Clifton Road, Mail Stop E–28,
Atlanta, GA 30303; telephone 404/498–
0003, fax 404/498–0059; E-mail:
slittle@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Agency Information Collection
Activities: Proposed Collection;
Comment Request
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Dated: February 24, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–3025 Filed 3–2–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–668B and CMS–
10181]
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
AGENCY:
E:\FR\FM\03MRN1.SGM
03MRN1
wwhite on PROD1PC61 with NOTICES
Federal Register / Vol. 71, No. 42 / Friday, March 3, 2006 / Notices
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Post Clinical
Laboratory Survey Questionnaire and
Supporting Regulations in 42 CFR
493.1771, 493.1773, and 493.1777; Use:
To provide an opportunity and a
mechanism for Clinical Laboratory
Improvement Amendments of 1988
(CLIA) laboratories surveyed by CMS or
CMS’ agents to express their satisfaction
and concerns about the CLIA survey
process.; Form Number: CMS–668B
(OMB #0938–0653); Frequency:
Recordkeeping, Reporting—Biennially;
Affected Public: Business or other forprofit and Not-for-profit institutions;
Number of Respondents: 21,000; Total
Annual Responses: 10,500; Total
Annual Hours: 2,625.
2. Type of Information Collection
Request: New collection; Title of
Information Collection: Enrolling LowIncome Beneficiaries into the Medicare
Prescription Drug Program—Survey of
State Agency Experiences; Use: The
Centers for Medicare and Medicaid
Services (CMS) will conduct a survey of
State Medicaid agencies, State health
insurance plans (SHIPs), and State
pharmaceutical assistance programs
(SPAPs) to identify best practices for the
successful enrollment of all types of
low-income Medicare beneficiaries into
a low-income subsidy and the Medicare
Part D Prescription Drug Benefit
Program. The evaluation will assist in
identifying the best practices, the factors
that make them effective, and how the
information can be disseminated in an
effective manor. The information will be
used to help CMS as it designs its
outreach and communication campaigns
in subsequent open enrollment periods.;
Form Number: CMS–10181 (OMB
#0938–NEW); Frequency: Reporting—
Other, one-time; Affected Public: State,
Local or Tribal governments, Federal
government; Number of Respondents:
126; Total Annual Responses: 126; Total
Annual Hours: 63.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’’ Web site
VerDate Aug<31>2005
16:43 Mar 02, 2006
Jkt 208001
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received at the address below, no
later than 5 p.m. on May 2, 2006. CMS,
Office of Strategic Operations and
Regulatory Affairs, Division of
Regulations Development—A,
Attention: Melissa Musotto (CMS–
668B), Room C4–26–05, 7500 Security
Boulevard, Baltimore, Maryland 21244–
1850.
Dated: February 22, 2006.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. 06–1919 Filed 3–2–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10110 and CMS–
10170]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
AGENCY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
10975
approved collection; Title of
Information Collection: Manufacturer
Submission of Average Sales Price
(ASP) Data for Medicare Part B Drugs
and Biologicals And Supporting
Regulations in 42 CFR 414.804; Form
No.: CMS–10110 (OMB #0938–0921);
Use: In accordance with section 1847A
of the Social Security Act (the Act),
Medicare Part B covered drugs and
biologicals not paid on a cost or
prospective payment basis are paid
based on the average sales price of the
drug or biological, beginning in CY
2005. The ASP data reporting
requirements are specified in section
1927 of the Act. The reported ASP data
are used to establish the Medicare
payment amounts. CMS will utilize the
ASP data to determine the drug
payment amounts for CY 2005 and
beyond. In the interim final rule which
published April 6, 2004 (69 FR 17935),
the ASP reporting format, (Addendum
A), was specified. In addition, we stated
that, as we gain more experience with
the ASP methodology, we may seek to
modify the reporting requirements (data
elements and format for submission) in
the future. Based on our experience
during the initial six reporting periods,
we have found it necessary for carrying
out section 1847A of the Act, to expand
the ASP data collected from
manufacturers.
We are proposing that, in addition to
the original data elements (manufacturer
name, National Drug Code (NDC),
manufacturer’s ASP, and number of
units), the following data elements must
be submitted quarterly by
manufacturers:
• Name of drug or biological;
• Strength of the product;
• Volume per item;
• Number of items per NDC;
• Wholesale acquisition costs (applies
to NDCs assigned to single source drug
and biological billing codes and NDCs
during the initial period under
section1847A(c)(4) of the Act);
• Expiration date of the last lot sold;
• Date NDC was first available for
sale; and
• Date of first sale.
We are also proposing that
manufacturers would no longer report
ASP data for an NDC beginning the
reporting period after the expiration
date of the last lot sold. For NDCs first
made available for sale or sold on or
after October 1, 2005, we are also
proposing to collect the date the NDC
was first available for sale and the date
of first sale. We are also proposing that
manufacturers be required to submit
these dates to us once with the first or
second, if applicable, data submission
for new NDCs. In addition, we are
E:\FR\FM\03MRN1.SGM
03MRN1
Agencies
[Federal Register Volume 71, Number 42 (Friday, March 3, 2006)]
[Notices]
[Pages 10974-10975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-1919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-668B and CMS-10181]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS) is publishing the following summary of proposed
collections for public comment. Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
[[Page 10975]]
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
1. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Post Clinical
Laboratory Survey Questionnaire and Supporting Regulations in 42 CFR
493.1771, 493.1773, and 493.1777; Use: To provide an opportunity and a
mechanism for Clinical Laboratory Improvement Amendments of 1988 (CLIA)
laboratories surveyed by CMS or CMS' agents to express their
satisfaction and concerns about the CLIA survey process.; Form Number:
CMS-668B (OMB 0938-0653); Frequency: Recordkeeping,
Reporting--Biennially; Affected Public: Business or other for-profit
and Not-for-profit institutions; Number of Respondents: 21,000; Total
Annual Responses: 10,500; Total Annual Hours: 2,625.
2. Type of Information Collection Request: New collection; Title of
Information Collection: Enrolling Low-Income Beneficiaries into the
Medicare Prescription Drug Program--Survey of State Agency Experiences;
Use: The Centers for Medicare and Medicaid Services (CMS) will conduct
a survey of State Medicaid agencies, State health insurance plans
(SHIPs), and State pharmaceutical assistance programs (SPAPs) to
identify best practices for the successful enrollment of all types of
low-income Medicare beneficiaries into a low-income subsidy and the
Medicare Part D Prescription Drug Benefit Program. The evaluation will
assist in identifying the best practices, the factors that make them
effective, and how the information can be disseminated in an effective
manor. The information will be used to help CMS as it designs its
outreach and communication campaigns in subsequent open enrollment
periods.; Form Number: CMS-10181 (OMB 0938-NEW); Frequency:
Reporting--Other, one-time; Affected Public: State, Local or Tribal
governments, Federal government; Number of Respondents: 126; Total
Annual Responses: 126; Total Annual Hours: 63.
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS''
Web site address at https://www.cms.hhs.gov/PaperworkReductionActof1995,
or e-mail your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call
the Reports Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received at the address below,
no later than 5 p.m. on May 2, 2006. CMS, Office of Strategic
Operations and Regulatory Affairs, Division of Regulations
Development--A, Attention: Melissa Musotto (CMS-668B), Room C4-26-05,
7500 Security Boulevard, Baltimore, Maryland 21244-1850.
Dated: February 22, 2006.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. 06-1919 Filed 3-2-06; 8:45 am]
BILLING CODE 4120-01-P